BioSpace News Archive

Drug Development

ABVC BioPharma Announces Vitargus® Phase II Study Plan Approved by HREC in Australia

ABVC Biopharma, Inc. today announced that its Vitrargus Phase II study plan was approved by the Australian Bellberry Human Research Ethics Committee (HREC) on September 29, 2022.

October 5, 2022
·
3 min read
Business

Evaxion welcomes Per Norlén as new CEO.

Evaxion Biotech A/S announces that its new Chief Executive Officer (CEO) Per Norlén has joined the company on October 3rd.

October 5, 2022
·
5 min read
Pharm Country

MiNK Selected for Five Presentations at Society for Immunotherapy of Cancer’s (SITC) 37th Annual Meeting

MiNK Therapeutics, Inc. announced the acceptance of five abstracts for presentation at the Society for Immunotherapy of Cancer’s 37th Annual Meeting, to be held November 8 – 12th, 2022.

October 5, 2022
·
2 min read
Genetown

Acer Therapeutics Announces Expansion of ACER-801 (osanetant) Development Indications to Include Post-Traumatic Stress Disorder

Acer Therapeutics Inc. today announced the expansion of ACER-801 (osanetant) into a new indication, for the reduction of the frequency and severity of acute stress disorder and post-traumatic stress disorder (PTSD).

October 5, 2022
·
7 min read
BioMidwest

Expert Panel Calls for Use of Blood Volume Measurement to Assess Heart Failure Patients at Key Scientific Meeting

Daxor Corporation announces that a scientific session titled “Debating Volume-based versus Pressure-based Methods and Devices to Measure Congestion in Heart Failure” was held during the Heart Failure Society of America Annual Scientific Meeting on October 3rd, 2022, in Washington, DC.

October 5, 2022
·
4 min read
Business

Palleon Co-Founder Dr. Carolyn Bertozzi Awarded Nobel Prize in Chemistry for Pioneering Methods of Studying Glycobiology

Palleon Pharmaceuticals announced that the company’s scientific co-founder Carolyn Bertozzi, Ph.D., has been awarded the 2022 Nobel Prize in Chemistry.

October 5, 2022
·
3 min read
Business

WishBone Medical Appoints Dr. John E. Herzenberg to Board of Directors

WishBone Medical, Inc., a leader in pediatric orthopedic medical devices, is pleased to announce the appointment of John Herzenberg, MD, FRCSC, FAAOS, to its board of directors.

October 5, 2022
·
2 min read
Business

The Ohio State University and Battelle Partner to Establish new NeuroTech Institute to Help Advance Neurolgical Research and Treatment

The Ohio State University and Battelle have partnered to launch an independent state-of-the art neurotechnology accelerator focused on treatments for patients with neurological disorders.

October 5, 2022
·
3 min read
CIRM awards $1.3 million to Greenstone Bio for innovative cardiovascular stem cell research

Greenstone Biosciences, Inc. (“Greenstone Bio”), a commercial-stage computational biology company, announces that the Company has received a DISC0 grant funding from the California Institute of Regenerative Medicine (CIRM).

October 5, 2022
·
2 min read
FDA

Humanetics Receives FDA Clearance to Begin Studies in Second Oncology Indication

FDA clears way for human trials of BIO 300 to mitigate erectile dysfunction in men undergoing radiation treatment for prostate cancer.

October 5, 2022
·
2 min read